Keith Lumbard

482 total citations
17 papers, 200 citations indexed

About

Keith Lumbard is a scholar working on Epidemiology, Infectious Diseases and Cancer Research. According to data from OpenAlex, Keith Lumbard has authored 17 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Cancer Research. Recurrent topics in Keith Lumbard's work include Cancer Genomics and Diagnostics (4 papers), Genetic factors in colorectal cancer (3 papers) and Herpesvirus Infections and Treatments (3 papers). Keith Lumbard is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Genetic factors in colorectal cancer (3 papers) and Herpesvirus Infections and Treatments (3 papers). Keith Lumbard collaborates with scholars based in United States, Netherlands and Mexico. Keith Lumbard's co-authors include Sally Hunsberger, Michael P. Fay, Lesia Dropulic, Jeffrey I. Cohen, Makinna Oestreich, Kening Wang, Lee-Jah Chang, Chetan Seshadri, Linda M. Scott and Yun Bai and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Keith Lumbard

15 papers receiving 199 citations

Peers

Keith Lumbard
Andrew Loughry United Kingdom
Panida Sriaroon United States
DeGaulle I. Chigbu United States
Robert P. Holman United States
Bénédict Fallet Switzerland
Jason Hockley United Kingdom
Andrew Loughry United Kingdom
Keith Lumbard
Citations per year, relative to Keith Lumbard Keith Lumbard (= 1×) peers Andrew Loughry

Countries citing papers authored by Keith Lumbard

Since Specialization
Citations

This map shows the geographic impact of Keith Lumbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Lumbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Lumbard more than expected).

Fields of papers citing papers by Keith Lumbard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Lumbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Lumbard. The network helps show where Keith Lumbard may publish in the future.

Co-authorship network of co-authors of Keith Lumbard

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Lumbard. A scholar is included among the top collaborators of Keith Lumbard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Lumbard. Keith Lumbard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mazzone, Peter J., Kwok‐Kin Wong, Jun-Chieh J. Tsay, et al.. (2023). Abstract 5766: Prospective evaluation of cell-free DNA fragmentomes for lung cancer detection. Cancer Research. 83(7_Supplement). 5766–5766. 2 indexed citations
2.
Erve, Iris van ’t, Keith Lumbard, L. Rinaldi, et al.. (2023). Abstract 5714: Cell-free DNA fragmentation profiling for monitoring therapeutic response in metastatic colorectal cancer. Cancer Research. 83(7_Supplement). 5714–5714. 2 indexed citations
3.
Skidmore, Zachary L., Iris van ’t Erve, Keith Lumbard, et al.. (2023). Cell-free DNA fragmentation profiling for therapeutic response monitoring in metastatic colorectal cancer.. Journal of Clinical Oncology. 41(16_suppl). e15664–e15664. 4 indexed citations
4.
Gallagher, Shannon, Jing Wang, Keith Lumbard, Lori E. Dodd, & Michael A. Proschan. (2022). Noninferiority testing with censoring when the event rate is low. Statistics in Medicine. 41(25). 5102–5112.
5.
Lumbard, Keith, Laurel A. Keefer, Jacob Carey, et al.. (2022). Abstract 2224: DELFI as a real-time treatment response assessment for patients with cancer. Cancer Research. 82(12_Supplement). 2224–2224. 1 indexed citations
6.
Wang, Kening, Lesia Dropulic, Sinthujan Jegaskanda, et al.. (2021). Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus–Seronegative Recipients of the HSV529 Vaccine. The Journal of Infectious Diseases. 224(9). 1509–1519. 5 indexed citations
7.
Hunsberger, Sally, Ana M. Ortega‐Villa, John H. Powers, et al.. (2020). Patterns of signs, symptoms, and laboratory values associated with Zika, dengue, and undefined acute illnesses in a dengue endemic region: Secondary analysis of a prospective cohort study in southern Mexico. International Journal of Infectious Diseases. 98. 241–249. 11 indexed citations
8.
Carter, Melody C., Irina Marić, Erica Brittain, et al.. (2020). A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis. Journal of Allergy and Clinical Immunology. 147(3). 1004–1010.e2. 26 indexed citations
9.
Kuang, Fei Li, Hawwa Alao, Nicole Holland‐Thomas, et al.. (2020). Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics. The Journal of Allergy and Clinical Immunology In Practice. 8(8). 2718–2726.e2. 17 indexed citations
10.
Han, Alison, Lindsay Czajkowski, Luz Angela Rosas, et al.. (2020). Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model. Clinical Infectious Diseases. 73(11). e4260–e4268. 36 indexed citations
11.
Fay, Michael P. & Keith Lumbard. (2020). Confidence intervals for difference in proportions for matched pairs compatible with exact McNemar's or sign tests. Statistics in Medicine. 40(5). 1147–1159. 12 indexed citations
12.
Lumbard, Keith, Carla Williams, Linden T. Hu, et al.. (2019). Post-treatment Lyme disease symptoms score: Developing a new tool for research. PLoS ONE. 14(11). e0225012–e0225012. 11 indexed citations
13.
Gouél‐Cheron, Aurélie, Keith Lumbard, Sally Hunsberger, et al.. (2019). Serial real-time RT-PCR and serology measurements substantially improve Zika and Dengue virus infection classification in a co-circulation area. Antiviral Research. 172. 104638–104638. 11 indexed citations
14.
Dropulic, Lesia, Makinna Oestreich, Kerry J. Laing, et al.. (2019). A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection. The Journal of Infectious Diseases. 220(6). 990–1000. 51 indexed citations
15.
Boulougoura, Afroditi, Erin E. Gabriel, Elizabeth Laidlaw, et al.. (2019). A Phase I, Randomized, Controlled Clinical Study of CC-11050 in People Living With HIV With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE). Open Forum Infectious Diseases. 6(6). ofz246–ofz246. 2 indexed citations
16.
Follmann, Dean, Erica Brittain, & Keith Lumbard. (2018). Half blind superiority tests for clinical trials of anti‐infective drugs. Statistics in Medicine. 38(1). 31–43.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026